SECTION PAGE 1.0 BACKGROUND 1 2.0 DEFINITIONS 2 3.0 ORGANIZATIONS 2 4.0 DEVELOPMENT PROGRAM 2 5.0 PRODUCT REGISTRATIONS 6 6.0 MANUFACTURE & SUPPLY 7 7.0 MANUFACTURING FEES 11 8.0 API & EXCIPIENTS 13 9.0 QUALITY MANAGEMENT 13 10.0 [NOT USED] 14 11.0...Development & Manufacturing Agreement • August 9th, 2012 • Cornerstone Therapeutics Inc • Pharmaceutical preparations
This AMENDED AND RESTATED DEVELOPMENT & MANUFACTURING AGREEMENT, (the “Agreement”) is effective as of November 6,2009 (the “Effective Date”) between EKR THERAPEUTICS, INC., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 1545 US Highway 206 Third Floor, Bedminster, New Jersey 07921 (“EKR”), and BAXTER HEALTHCARE CORPORATION, a corporation organized and existing under the laws of the State of Delaware and having its principal office at One Baxter Parkway, Deerfield, Illinois 60015 (“Baxter”). All references to “EKR” and “Baxter” will include their respective Affiliates.
